These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34849337)

  • 1. Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey.
    Küçükdiler AHE; Yavaşoğlu İ; Selim C; Mutlu CA; Karakuş A; Koyuncu MB; Bilgir O; Ayyıldız O; Tiftik EN; Bolaman AZ
    Leuk Res Rep; 2021; 16():100280. PubMed ID: 34849337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
    Ho VT; Martin AS; Pérez WS; Steinert P; Zhang MJ; Chirnomas D; Hoang CJ; Loberiza FR; Saber W
    Biol Blood Marrow Transplant; 2020 May; 26(5):884-892. PubMed ID: 31891815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia.
    Norsworthy KJ; Ko CW; Lee JE; Liu J; John CS; Przepiorka D; Farrell AT; Pazdur R
    Oncologist; 2018 Sep; 23(9):1103-1108. PubMed ID: 29650683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia.
    Cortes JE; de Lima M; Dombret H; Estey EH; Giralt SA; Montesinos P; Röllig C; Venditti A; Wang ES
    J Hematol Oncol; 2020 Oct; 13(1):137. PubMed ID: 33059764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Gemtuzumab Ozogamicin as Salvage Therapy in Patients with Acute Myeloid Leukemia: A Monocentric Real-World Experience.
    Açar İH; Guvenc B
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984499
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.
    Arceci RJ; Sande J; Lange B; Shannon K; Franklin J; Hutchinson R; Vik TA; Flowers D; Aplenc R; Berger MS; Sherman ML; Smith FO; Bernstein I; Sievers EL
    Blood; 2005 Aug; 106(4):1183-8. PubMed ID: 15886328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience.
    Hosono N; Ookura M; Araie H; Morita M; Itoh K; Matsuda Y; Yamauchi T
    Int J Hematol; 2021 Mar; 113(3):362-369. PubMed ID: 33219461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation.
    Duncan C; St Martin A; Pérez WS; Steinert P; Zhang MJ; Chirnomas D; Hoang CJ; Loberiza FR; Saber W
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29067. PubMed ID: 33871892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience.
    Pawinska-Wasikowska K; Czogala M; Skoczen S; Surman M; Rygielska M; Ksiazek T; Pac A; Wieczorek A; Skalska-Sadowska J; Samborska M; Wachowiak J; Chaber R; Tomaszewska R; Szczepanski T; Zielezinska K; Urasinski T; Moj-Hackemer M; Kalwak K; Kozlowska M; Irga-Jaworska N; Balwierz W; Bukowska-Strakova K
    Front Immunol; 2023; 14():1268993. PubMed ID: 38187390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low doses of gemtuzumab ozogamicin in adults diagnosed with acute myeloid leukaemia.
    Peña Domingo M; Vives Polo S; Garrido Díaz A; Coll Jordà R; Ribera Santasusana JM; Ferrá Coll C
    Med Clin (Barc); 2021 Oct; 157(7):325-328. PubMed ID: 33268129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of gemtuzumab ozogamicin in the treatment of pediatric relapsed/ refractory Acute Myeloid Leukemia.
    Ünal E; Sahdev I
    Turk J Haematol; 2008 Mar; 25(1):36-41. PubMed ID: 27264148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group.
    Niktoreh N; Lerius B; Zimmermann M; Gruhn B; Escherich G; Bourquin JP; Dworzak M; Sramkova L; Rossig C; Creutzig U; Reinhardt D; Rasche M
    Haematologica; 2019 Jan; 104(1):120-127. PubMed ID: 30093401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
    Bross PF; Beitz J; Chen G; Chen XH; Duffy E; Kieffer L; Roy S; Sridhara R; Rahman A; Williams G; Pazdur R
    Clin Cancer Res; 2001 Jun; 7(6):1490-6. PubMed ID: 11410481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.
    Chevallier P; Delaunay J; Turlure P; Pigneux A; Hunault M; Garand R; Guillaume T; Avet-Loiseau H; Dmytruk N; Girault S; Milpied N; Ifrah N; Mohty M; Harousseau JL
    J Clin Oncol; 2008 Nov; 26(32):5192-7. PubMed ID: 18854573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience.
    Penel-Page M; Plesa A; Girard S; Marceau-Renaut A; Renard C; Bertrand Y
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28305. PubMed ID: 32307866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia.
    Debureaux PE; Labopin M; Mamez AC; Lapusan S; Isnard F; Adaeva R; Bonnin A; Hirsch P; Delhommeau F; Battipaglia G; Duléry R; Malard F; Vekhoff A; Mohty M; Legrand O; Brissot E
    Bone Marrow Transplant; 2020 Feb; 55(2):452-460. PubMed ID: 31554931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.
    Yamaguchi Y; Usui N; Dobashi N; Yano S; Yahagi Y; Takei Y; Sugiyama K; Ogasawara Y; Saito T; Minami J; Kobayashi T; Katsube A; Kamiyama Y; Machishima T; Morikawa N; Otsubo H; Kaito K; Asai O; Aiba K
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1105-9. PubMed ID: 19620797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia.
    Wang ES; Aplenc R; Chirnomas D; Dugan M; Fazal S; Iyer S; Lin TL; Nand S; Pierce KJ; Shami PJ; Vermette JJ; Abboud CN
    Leuk Lymphoma; 2020 Aug; 61(8):1965-1973. PubMed ID: 32432489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
    Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.